Building a healthcare buzz

In this paper, BuzzMetrics review findings from analyses of online consumer buzz for two sets of promising drug therapies.

Building a healthcare buzz

Lydia WorthingtonHealthcare, BuzzMetrics, United States

EXECUTIVE SUMMARY

Building even a small amount of buzz before a product is launched can have a vast, positive impact on the amount of discussion a product merits after it has been released. To test this theory, BuzzMetrics collected word-of-mouth discussion data on two sets of new drugs: the oncology therapies Abraxane and Tarceva, and the treatments for chronic illnesses Tysabri and Byetta.

Through our proprietary analytic methodology and software, we collected buzz among relevant online patient and caregiver forums for each therapeutic category. We tracked the level of discussion...

Not a subscriber?

Schedule your live demo with our team today

WARC helps you to plan, create and deliver more effective marketing

  • Prove your case and back-up your idea

  • Get expert guidance on strategic challenges

  • Tackle current and emerging marketing themes

We’re long-term subscribers to WARC and it’s a tool we use extensively. We use it to source case studies and best practice for the purposes of internal training, as well as for putting persuasive cases to clients. In compiling a recent case for long-term, sustained investment in brand, we were able to support key marketing principles with numerous case studies sourced from WARC. It helped bring what could have been a relatively dry deck to life with recognisable brand successes from across a broad number of categories. It’s incredibly efficient to have such a wealth of insight in one place.

Insights Team
Bray Leino

You’re in good company

We work with 80% of Forbes' most valuable brands* and 80% of the world's top top-of-the-class agencies.

* Top 10 brands